| Today, Sun, Nov 8, 2009 | | | New Star Analyst Rankings for Oncolytics Biotech, Inc. StarMine (Sun 9:19am)
| | Fri, Nov 6, 2009 | | | Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting PR Newswire (Fri, Nov 6)
| | Thu, Nov 5, 2009 | | | Oncolytics Biotech(R) Inc. Announces 2009 Third Quarter Results PR Newswire (Thu, Nov 5)
| | Tue, Nov 3, 2009 | | | Oncolytics Biotech(R) Inc. Announces Results of Second Warrant Expiry Date Acceleration Program PR Newswire (Tue, Nov 3)
| | Mon, Nov 2, 2009 | | | Media Advisory - Oncolytics Biotech(R) Inc. to Present at BIO-Europe 2009 PR Newswire (Mon, Nov 2)
| | Fri, Oct 30, 2009 | | | Oncolytics Biotech(R) Inc. Collaborators to Present Phase II Sarcoma Trial Results at CTOS Annual Meeting PR Newswire (Fri, Oct 30)
| | Tue, Oct 27, 2009 | | | Oncolytics(R) Biotech Inc. Announces Issuance of 33rd U.S. Patent PR Newswire (Tue, Oct 27)
| | Mon, Oct 26, 2009 | | | Oncolytics Biotech(R) Inc. Announces Results of First Warrant Expiry Date Acceleration Program PR Newswire (Mon, Oct 26)
| | Fri, Oct 23, 2009 | | | Media Advisory - Oncolytics Biotech Inc. to Present at BIO Investor Forum 2009 PR Newswire (Fri, Oct 23)
| | Tue, Oct 20, 2009 | | | Oncolytics Biotech(R) Inc. Announces Investment in Private Biotechnology Company PR Newswire (Tue, Oct 20)
| | Wed, Oct 7, 2009 | | | Media Advisory - Oncolytics Biotech(R) Inc. to Present at BioPartnering Europe PR Newswire (Wed, Oct 7)
| | | StockPreacher.com Issues Trading Overview for Oncolytics Biotech Inc. GlobeNewswire (Wed, Oct 7)
| | Fri, Oct 2, 2009 | | | Oncolytics Biotech(R) Inc. Accelerates Warrant Expiry Date PR Newswire (Fri, Oct 2)
| | | Oncolytics Biotech(R) Inc. Reaches Special Protocol Assessment Agreement with the FDA on Design of Phase 3 Trial for REOLYSIN(R) in Head and Neck Cancers PR Newswire (Fri, Oct 2)
| | Thu, Oct 1, 2009 | | | Oncolytics Biotech(R) Inc. Announces Phase 3 Update Conference Call PR Newswire (Thu, Oct 1)
| | Mon, Sep 28, 2009 | | | [video] The Pisani Paradox at TheStreet.com (Mon, Sep 28)
| | Thu, Sep 24, 2009 | | | Oncolytics Biotech(R) Inc. Announces Reovirus and Cisplatin Research Supports U.S. Phase 2 Metastatic Melanoma Trial PR Newswire (Thu, Sep 24)
| | | Oncolytics Biotech(R) Inc. Announces Start of Enrolment in U.S. Phase 2 Melanoma Cancer Clinical Trial PR Newswire (Thu, Sep 24)
| | Wed, Sep 23, 2009 | | | Oncolytics Biotech Inc.(R) Accelerates Warrant Expiry Date PR Newswire (Wed, Sep 23)
| | Fri, Sep 18, 2009 | | | Oncolytics Biotech Inc. Confirms No Material Undisclosed Information CNW Group (Fri, Sep 18)
| Add ONCY News to My Yahoo!:

| |
|